These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1061 related items for PubMed ID: 17974436

  • 1. [The effect of sera of breast cancer patients on NK cell activity].
    Konjević G, Spuzić I.
    Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of different effects of sera of breast cancer patients on the activity of natural killer cells.
    Konjević G, Spuzić I.
    J Clin Lab Immunol; 1992; 38(2):83-93. PubMed ID: 1343351
    [Abstract] [Full Text] [Related]

  • 3. [Immunomodulatory effect of serum on NK cells in vitro in healthy individuals].
    Konjević G, Spuzić I.
    Glas Srp Akad Nauka Med; 1994; (44):45-54. PubMed ID: 7590414
    [Abstract] [Full Text] [Related]

  • 4. Stage dependence of NK cell activity and its modulation by interleukin 2 in patients with breast cancer.
    Konjević G, Spuzić I.
    Neoplasma; 1993; 40(2):81-5. PubMed ID: 8350959
    [Abstract] [Full Text] [Related]

  • 5. [The possibilities of modulation of NK cell activity].
    Konjević G, Spuzić I.
    Glas Srp Akad Nauka Med; 2002; (47):89-101. PubMed ID: 16078444
    [Abstract] [Full Text] [Related]

  • 6. [The effect of serum on NK cell activity].
    Konjević G, Spuzić I.
    Glas Srp Akad Nauka Med; 1991; (41):113-20. PubMed ID: 1916438
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Modulation of natural killer cell activity by serum from cancer patients: preliminary results of a study of patients with colorectal adenocarcinoma or other types of cancer.
    Pislarasu M, Oproiu A, Taranu D, Herberman RB, Sulica A.
    Cancer Res; 1988 May 01; 48(9):2596-603. PubMed ID: 3356020
    [Abstract] [Full Text] [Related]

  • 9. In vitro enhancement of peripheral blood mononuclear cell natural killer activity following short term incubation with fetal calf serum.
    Lauer SJ, Finlan J, Borella LD, Piaskowski VD, Casper JT.
    J Clin Lab Immunol; 1983 Oct 01; 12(2):105-10. PubMed ID: 6606047
    [Abstract] [Full Text] [Related]

  • 10. [Alterations in NK cell activity in the presence of sera of patients with metastases].
    Konjević G, Spuzić I.
    Srp Arh Celok Lek; 1994 Oct 01; 122 Suppl 1():78-80. PubMed ID: 18173196
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cytolysis of mammary tumor targets by resting, interleukin-2 stimulated and in vitro cultured peripheral blood lymphocytes from breast cancer patients.
    Brenner BG, McCrea EL, Margolese RG.
    Anticancer Res; 1988 Oct 01; 8(4):653-8. PubMed ID: 3263077
    [Abstract] [Full Text] [Related]

  • 13. Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism.
    Rook AH, Hooks JJ, Quinnan GV, Lane HC, Manischewitz JF, Macher AM, Masur H, Fauci AS, Djeu JY.
    J Immunol; 1985 Mar 01; 134(3):1503-7. PubMed ID: 3918102
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A pilot study of intralymphatic interleukin-2. I. Cytotoxic and surface marker changes of peripheral blood lymphocytes.
    Shau H, Isacescu V, Ibayashi Y, Tokuda Y, Golub SH, Fahey JL, Sarna GP.
    J Biol Response Mod; 1990 Feb 01; 9(1):71-80. PubMed ID: 2319261
    [Abstract] [Full Text] [Related]

  • 16. Studies on the mechanism of natural killer cytotoxicity. II. coculture of human PBL with NK-sensitive or resistant cell lines stimulates release of natural killer cytotoxic factors (NKCF) selectively cytotoxic to NK-sensitive target cells.
    Wright SC, Weitzen ML, Kahle R, Granger GA, Bonavida B.
    J Immunol; 1983 May 01; 130(5):2479-83. PubMed ID: 6833762
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Assessment of host immune response in breast cancer patients.
    Akimoto M, Ishii H, Nakajima Y, Iwasaki H, Tan M, Abe R, Kasai M.
    Cancer Detect Prev; 1986 May 01; 9(3-4):311-7. PubMed ID: 3488806
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.